TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2018: $7.77M2019: $145.34M2020: $296.48M2021: $150.67M2022: $85.57M2023: $74.15M2024: $63.18M2025: $39.46M$39.46M
2018Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$39.46M-37.5%
2024$63.18M-14.8%
2023$74.15M-13.3%
2022$85.57M-43.2%
2021$150.67M-49.2%
2020$296.48M+104.0%
2019$145.34M+1771.0%
2018$7.77M—